Yale School of Medicine appoints chair of surgery department

November 18, 2017
Nita Ahuja, MD, has been named chair of the department of surgery at Yale School of Medicine. Ahuja also will serve as chief of surgery at Yale New…
In the Journals Plus

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype

November 17, 2017
Radiotherapy prolonged OS among patients with all stages of nodular lymphocytic Hodgkin lymphoma, including those with B-symptoms, according to study…
Meeting News

High compliance with Optune linked to greatest survival benefit for glioblastoma

November 17, 2017
Patients with newly diagnosed glioblastoma who used the Optune device more than 90% of the time had the greatest chance for survival, according to a…

ASCO expands enrollment for TAPUR study

November 17, 2017
ASCO announced four cohorts of Targeted Agent and Profiling Utilization Registry, or TAPUR, will enroll additional patients with a variety of…
Meeting NewsVideo

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017
MIAMI Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal…

Liver tumor program launched to ‘work in a fashion of teamwork’

November 17, 2017
The Perlmutter Cancer Center at NYU Langone Health launched a new liver tumor program, designed to provide multidisciplinary care for patients with…
Meeting News

Women underutilize CT scans for lung cancer

November 17, 2017
Women were less likely to use CT scans for lung cancer screening than men, even though they are higher risk than men for the disease, according to a…
FDA News

FDA approves Sutent to reduce risk for recurrent kidney cancer

November 16, 2017
The FDA today approved sunitinib malate for the adjuvant treatment of adults at high risk for recurrent renal cell carcinoma following nephrectomy. …
FDA News

FDA approves Gazyva for treatment-naive advanced follicular lymphoma

November 16, 2017
The FDA approved use of obinutuzumab as part of a therapeutic regimen for patients with treatment-naive advanced follicular lymphoma, according to…
FDA News

FDA approves Hemlibra for hemophilia A

November 16, 2017
The FDA today approved emicizumab-kxwh to prevent or reduce the frequency of bleeding episodes among patients with hemophilia A who have developed…
Meeting News

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

November 16, 2017
WASHINGTON — When diagnosed with
FDA News

FDA grants CAR T-cell therapy bb2121 breakthrough therapy designation for multiple myeloma

November 16, 2017
The FDA granted bb2121 — a chimeric antigen receptor T-cell therapy
In the Journals PlusPerspective

Lomustine, bevacizumab fail to improve OS in progressive glioblastoma

November 16, 2017
The addition of lomustine to bevacizumab failed to confer a survival advantage for the treatment of progressive glioblastoma, according to results of…

Nine updates for World Pancreatic Cancer Day

November 16, 2017
World Pancreatic Cancer Day will be observed today. The World Pancreatic Cancer Coalition has united more than 60 organizations from 27 countries to…
In the Journals

Fatty liver linked to colorectal cancer in men, breast cancer in women

November 15, 2017
Researchers observed that nonalcoholic fatty liver disease was associated with hepatocellular carcinoma in general and with colorectal cancer in men…
Meeting News

AMA adopts new strategy for genetic tests, therapeutics

November 15, 2017
AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and…
Meeting News

More clinical trials needed in metastatic colorectal cancer

November 15, 2017
NEW YORK —A significant amount of development in colorectal carcinoma treatment has occurred in recent years, but the 5-year OS rates are still…
FDA News

FDA authorizes IMPACT test to rapidly identify cancer mutations

November 15, 2017
The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation…
In the Journals

Colon cancer treatment, survival improving in older patients

November 15, 2017
The quality of care received by older patients with colon cancer has significantly improved since 2001, but adherence to treatment guidelines could…
FDA News

FDA approves Faslodex in combination with Verzenio for advanced breast cancer

November 15, 2017
The FDA expanded the indication of fulvestrant to include its use with abemaciclib for treatment of certain women with advanced or metastatic breast…
Advertisement
Advertisement